20 insiders have filed at ANIP since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Meridian Venture Partners II Lp | 10% owner | 1.82M | 8.444% | 1 sells $11.7M | |
| Meridian Venture Partners II, Co. | 10% owner | 1.82M | 8.444% | 1 sells $11.7M | |
| Meridian Venture Partners II Gp, L.P. | 10% owner | 1.82M | 8.444% | 1 sells $11.7M | |
| Brown Robert E. JR | 10% owner | 1.82M | 8.444% | 1 sells $11.7M | |
| Shanmugam Muthusamy | Head Of R&d, COO-Novitium Ops | 538.0k | 2.497% | 57 sells $56.6M | |
| Lalwani Nikhil | President & CEO | 404.9k | 1.879% | 8 sells $14.9M | |
| Gassert Chad | SVP - Corp. Dev. & Strategy | 233.4k | 1.083% | 12 sells $14.1M | |
| Carey Stephen P. | SVP & CFO | 180.4k | 0.837% | 7 sells $7.2M | |
| Marken James G. | SVP Ops & Prod Dev | 117.8k | 0.547% | 2 sells $1.9M | |
| Mutz Christopher | Head Of Rare Disease | 91.3k | 0.424% | 11 sells $2.9M | |
| Gutwerg Ori | SVP, Generics | 81.5k | 0.378% | 8 sells $2.2M | |
| Cook Meredith | SR. VP, General Counsel & Sec. | 79.4k | 0.369% | 29 sells $678k | |
| Walsh Patrick D | Director | 52.4k | 0.243% | 3 sells $2.0M | |
| Davis Krista | SVP, Chief Hr Officer | 51.9k | 0.241% | 12 sells $1.6M | |
| Rowland Thomas Andrew | SVP, Head - Established Brands | 38.7k | 0.18% | 2 sells $784k | |
| Haughey Thomas | Director | 36.5k | 0.17% | 1 sells $1.7M | |
| Tannenbaum Renee P | Director | 25.2k | 0.117% | 2 sells $274k | |
| Thoma Jeanne | Director | 23.4k | 0.109% | 2 sells $1.9M | |
| Pera Antonio R | Director | 22.7k | 0.105% | 4 sells $1.8M | |
| Leonard Matthew J | Director | 6.9k | 0.032% | 2 sells $841k |
Full register at boothcheck.com/insiders/ANIP. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.